Abbott (NYSE: ABT) and BG Medicine, Inc. announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott’s ARCHITECT immunochemistry instrument platform, specifically the company’s i1000SR and i2000SR instruments. The agreement grants Abbott a [...]

Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced the FDA approval and US launch of its high throughput haemostasis analyzer, the Destiny Max.

Advanced Analytical, based in Ames, IA will reveal the latest results generated from their new instrument platform, the DNA PROfiler(TM) system. This instrument rapidly identifies microorganisms in less than 4 hours by producing a genetic fingerprint or PROfile. The generated fingerprint when compared to a database of known organisms can be used for either genus [...]